Anabold – Methandrostenolone 25 mg/mL | 10 mL | Omega Lab
1. Product Overview
Anabold is described by Roidsdeal as an injectable methandrostenolone product associated with Omega Lab.
The declared concentration is 25 mg/mL, with 10 mL per vial.
The supplied Finest Gears description also provisionally identifies methandrostenolone but reports a conflicting reference to boldenone undecylenate in an earlier description.
Because these compounds are different anabolic steroids, the finished product’s identity requires manufacturer confirmation.
2. What Is Anabold?
Anabold is provisionally identified as containing methandrostenolone, also known as methandienone or Dianabol.
Methandrostenolone is a synthetic testosterone-derived anabolic-androgenic steroid.
It is more commonly associated with oral formulations. Therefore, the claimed injectable presentation requires particular attention to its composition, sterility, and manufacturing documentation.
The supplied information does not establish the specific injection route or inactive ingredients.
3. How Does Methandrostenolone Work?
Methandrostenolone interacts with androgen receptors and influences androgen-responsive biological processes.
Its principal pharmacological characteristics include:
- Androgen Receptor Activation: Influences gene expression and tissue metabolism.
- Anabolic Activity: Affects protein metabolism and nitrogen balance.
- Estrogen-Related Effects: Can undergo aromatization, contributing to fluid retention and gynecomastia.
- Hormonal Suppression: Can suppress endogenous testosterone production.
These pharmacological properties do not establish safe or predictable performance benefits from Anabold.
4. Medical Uses & Clinical Information
Historical Medical Use: Methandrostenolone has a history of medical use as an anabolic-androgenic steroid.
Anabolic Physiology: Its effects on androgen signaling and protein metabolism have been investigated.
Body Composition Claims: Roidsdeal promotes muscle mass and strength development. These claims do not establish approved therapeutic indications or verified effectiveness.
Injectable Formulation: No verified clinical evidence, prescribing information, or formulation documentation has been supplied for injectable Omega Lab Anabold.
Regulatory Context: Methandrostenolone is not currently FDA-approved for human therapeutic use in the United States.
5. Product Specifications & Packaging
| Specification | Details |
|---|---|
| Product Name | Anabold |
| Listed Manufacturer | Omega Lab |
| Provisional Active Ingredient | Methandrostenolone |
| Alternative Names | Methandienone / Dianabol |
| Chemical Class | Testosterone-Derived Anabolic Steroid |
| Declared Concentration | 25 mg/mL |
| Product Form | Injectable Solution (Unverified) |
| Package Size | 10 mL Vial |
| Total Declared Content | 250 mg |
| Specific Injection Route | Not Verified |
| Formulation Excipients | Not Provided |
| Sterility Documentation | Not Provided |
| US Controlled Substance Status | Schedule III |
| WADA Status | Prohibited |
| Product-Specific FDA Approval | Not Established |
| Batch-Specific COA | Not Provided |
The reported ingredient conflict prevents confirmation of the actual finished formulation.
6. Administration & Medical Supervision
Anabold is described as an injectable product.
The concentration of 25 mg/mL is a declared specification, not a recommended dose.
The supplied information does not identify whether the formulation is intended for intramuscular, subcutaneous, or another injection route.
An injectable product with unverified composition or sterility can present serious health risks.
No injection technique, dosage schedule, or bodybuilding protocol is established by the available information.
7. Possible Side Effects & Safety Limitations
Potential adverse effects associated with methandrostenolone include:
- Liver injury and abnormal liver enzymes
- Elevated blood pressure
- Adverse cholesterol changes
- Cardiovascular complications
- Fluid retention and gynecomastia
- Suppression of natural testosterone production
- Reduced fertility
- Acne, oily skin, and hair loss
- Mood and behavioral changes
- Virilization in females
Additional Injectable Risks: Contamination, infection, tissue injury, allergic reactions, and complications involving unverified formulation ingredients.
Methandrostenolone is a 17-alpha-alkylated steroid, a structural characteristic associated with hepatic safety concerns.
8. Warnings & Precautions
Methandrostenolone is a Schedule III controlled anabolic steroid in the United States.
Individuals with liver disease, cardiovascular conditions, hypertension, endocrine disorders, or reproductive concerns may face additional risks.
Exposure during pregnancy may cause fetal harm.
Methandrostenolone is prohibited under WADA regulations.
The unresolved methandrostenolone-versus-boldenone discrepancy is a critical safety concern.
Claims of high purity, fast absorption, and pharmaceutical manufacturing standards remain unsubstantiated.
9. Storage & Handling
Anabold is described as a 10 mL injectable preparation.
Verified storage temperatures, stability data, expiration requirements, and sterility specifications have not been supplied.
A sealed vial does not independently establish sterility or suitability for human administration.
Authentic manufacturer documentation is necessary to determine appropriate handling requirements.
10. Frequently Asked Questions (FAQs)
Q1: What is the active ingredient in Anabold?
Roidsdeal identifies methandrostenolone. The supplied Finest Gears text reports a conflicting boldenone undecylenate identification in an earlier description. Manufacturer confirmation is required.
Q2: What is the declared concentration?
The supplied information identifies 25 mg/mL.
Q3: What is the package size?
The declared package contains one 10 mL vial.
Q4: Is Anabold an injectable product?
It is described as injectable, but its formulation, sterility, and specific administration route remain unverified.
Q5: Is Anabold FDA-approved?
FDA approval of this specific Omega Lab product has not been established.
11. Conclusion & Medical Disclaimer
Anabold is provisionally described as a Methandrostenolone 25 mg/mL injectable product supplied in a 10 mL vial.
However, the supplied material reports a significant ingredient discrepancy involving boldenone undecylenate.
Actual ingredient identity, concentration, formulation, sterility, manufacturing quality, and regulatory authorization remain unverified.
Medical Disclaimer: This information is provided for educational and product-identification purposes only. It does not constitute medical advice, injection instructions, dosing guidance, or a recommendation for nonmedical anabolic steroid use.



